Covidien (COV +0.00%) shares are up more than 20% today on stellar news that dividend aristocrat Medtronic (MDT 0.53%) is moving in to acquire the medical device maker for $42.9 billion. Inevitably, there is a lot of information in the press release -- so let's condense it down to three quick things you need to know.
In the video below, health care analyst Michael Douglass lays out the three quick facts about the proposed Covidien-Medtronic deal that immediately piqued his interest, and why the price looks like an exciting deal for Covidien shareholders.
